[HTML][HTML] L-arginine/nitric oxide pathway is altered in colorectal cancer and can be modulated by novel derivatives from oxicam class of non-steroidal anti-inflammatory …

M Krzystek-Korpacka, B Szczęśniak-Sięga, I Szczuka… - Cancers, 2020 - mdpi.com
Simple Summary Nitric oxide and arginine metabolism in colorectal cancer (CRC) holds
potential for therapeutic intervention. We hypothesized that it can be modulated by oxicams …

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory …

M Krzystek-Korpacka, B Szczesniak-Siega, I Szczuka… - Cancers, 2020 - go.gale.com
Nitric oxide and arginine metabolism in colorectal cancer (CRC) holds potential for
therapeutic intervention. We hypothesized that it can be modulated by oxicams, a class of …

[PDF][PDF] L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti …

M Krzystek-Korpacka, B Szczesniak-Siega, I Szczuka… - 2021 - ppm.umw.edu.pl
L-arginine/nitric oxide pathway metabolites are altered in colorectal cancer (CRC). We
evaluated underlying changes in pathway enzymes in 55 paired tumor/tumor-adjacent …

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory …

M Krzystek-Korpacka, B Szczęśniak-Sięga, I Szczuka… - Cancers, 2020 - europepmc.org
L-arginine/nitric oxide pathway metabolites are altered in colorectal cancer (CRC). We
evaluated underlying changes in pathway enzymes in 55 paired tumor/tumor-adjacent …

[HTML][HTML] L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti …

M Krzystek-Korpacka, B Szczęśniak-Sięga, I Szczuka… - Cancers, 2020 - ncbi.nlm.nih.gov
L-arginine/nitric oxide pathway metabolites are altered in colorectal cancer (CRC). We
evaluated underlying changes in pathway enzymes in 55 paired tumor/tumor-adjacent …

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory …

M Krzystek-Korpacka, B Szczęśniak-Sięga… - …, 2020 - pubmed.ncbi.nlm.nih.gov
L-arginine/nitric oxide pathway metabolites are altered in colorectal cancer (CRC). We
evaluated underlying changes in pathway enzymes in 55 paired tumor/tumor-adjacent …

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory …

M Krzystek-Korpacka, B Szczęśniak-Sięga… - …, 2020 - search.ebscohost.com
Abstract Simple Summary: Nitric oxide and arginine metabolism in colorectal cancer (CRC)
holds potential for therapeutic intervention. We hypothesized that it can be modulated by …

[PDF][PDF] L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti …

M Krzystek-Korpacka, B Szczesniak-Siega, I Szczuka… - pdfs.semanticscholar.org
L-arginine/nitric oxide pathway metabolites are altered in colorectal cancer (CRC). We
evaluated underlying changes in pathway enzymes in 55 paired tumor/tumor-adjacent …

[PDF][PDF] L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti …

M Krzystek-Korpacka, B Szczesniak-Siega, I Szczuka… - 2021 - ppm.umw.edu.pl
L-arginine/nitric oxide pathway metabolites are altered in colorectal cancer (CRC). We
evaluated underlying changes in pathway enzymes in 55 paired tumor/tumor-adjacent …